Home » Bigger Contribution to Healthcare Overhaul May Be Inevitable for PhRMA
Bigger Contribution to Healthcare Overhaul May Be Inevitable for PhRMA
PhRMA’s $80 billion deal with the White House to help finance healthcare overhaul legislation could potentially expand, and drugmakers may find
it difficult to avoid paying a higher price, an expert says. PhRMA “essentially made a political decision at the beginning of this process that they
were going to be on the inside at the table, and [the $80 billion deal] was their admission price,” Edmund Haislmaier, a senior research fellow at
the Heritage Foundation, said Thursday. “Now they’re finding out … that the price just went up.”
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May